Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will highlight the company’s latest spinal
implant and enabling technology innovations at the North American
Spine Society (NASS) Annual Meeting held September 25-28, 2019 in
Chicago, IL at booth #2218.
“We are proud to be a NASS sponsor and this year’s meeting is
very exciting as we plan to unveil several new technologies poised
for launch,” said Dave Demski, Chief Executive Officer. “With the
addition of the ExcelsiusGPS® Interbody Solutions platform, we will
demonstrate the integration of our best-in-class surgical planning,
robotic navigation, and expandable interbody technologies designed
to enhance operating room efficiency and improve clinical results
in spine surgery.”
The company’s participation includes in-booth surgeon
presentations on the next evolution of the ExcelsiusGPS® platform
featuring Interbody Solutions. This new solution offers navigation
with constant real-time feedback during dilation, disc preparation,
and implant insertion to help achieve optimal implant placement for
minimally invasive posterior and lateral lumbar interbody fusion
procedures. The platform’s rigid robotic arm maximizes retractor
stability and creates a strong and stable working channel. Using
today’s most comprehensive, robotic-assisted spine surgery
platform, surgeons will be able to navigate instruments and
implants with the most advanced expandable interbody portfolio on
the market.
The exhibit will also include live demonstrations of Globus
Medical’s Single Position Lateral Surgery technique, which has been
increasingly utilized by surgeons over the last few years. Single
Position Lateral Surgery is a fully integrated procedural solution
that combines robotic and navigation enabling technologies with
advanced musculoskeletal implant systems to treat complex
multi-level spine pathologies from a single lateral position.
Procedures that traditionally required multi-staged surgery using
anterior, lateral, and posterior patient positions to treat spinal
levels including L5-S1 can now be performed while the patient
remains in one lateral position. This technique has the
potential to provide tangible benefits for surgeons, hospitals, and
patients in terms of time, accuracy, surgical efficiency, and
reduced radiation exposure through a holistic surgical
solution.
Additional new technologies will be exhibited including CREO®
NXT Stabilization System, SI-LOK® Select Sacroiliac Joint Fixation,
and the full line of HEDRON™ 3D Printed Spacers.
Globus welcomes NASS attendees to
visit globusmedical.com/nass-2019 for a complete list of event
details and to register for the presentations featured below:
Wednesday, September 25th The Next
Evolution of Posterior MIS with ExcelsiusGPS® Interbody
Solutions10:00am -10:30am, Exhibit Hall Booth #2218Sheeraz
Qureshi, MD, MBASingle Position Lateral Surgery with
ExcelsiusGPS® and Expandable Technology 3:05 pm – 3:35 pm,
Exhibit Hall Booth #2218Vladimir Sinkov, MD
Thursday, September 26th
HEDRON™ 3D Printed Spacers: Engineered for
Fusion 3:00 pm – 3:30 pm, Exhibit Hall Booth #2218Frank La
Marca, MD
NASS After Hours featuring ExcelsiusGPS®: A
Comprehensive Solution for Spine SurgeryPresentation: 3:30
pm - 5:15 pm, Gold Theater, Exhibit Hall Booth #1310BioSkills Lab:
5:00 pm – 8:00 pm, Orange Lab, Exhibit Hall Booth #1310Hoon Choi,
MD, MS
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
comply with changing laws and regulations that are applicable to
our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us,
trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsSenior Vice
President, Business Development and Investor RelationsPhone: (610)
930-1800Email: investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024